Format

Send to

Choose Destination
Pak J Pharm Sci. 2014 Jul;27(4):859-64.

Hypoglycemic effect of triterpenoid-rich extracts from Euryale ferox shell on normal and streptozotocin-diabetic mice.

Author information

1
College of Biotechnology and Food Engineering, Hefei University of Technology, Hefei, China /College of Biosystem Engineering and Food Science, Zhejiang University, Hangzhou, China.
2
College of Biotechnology and Food Engineering, Hefei University of Technology, Hefei, China.
3
School of Mathematical Physics and Biology Engineering, Inner Mongolia University of Science and Technology, Baotou, China / College of Biosystem Engineering and Food Science, Zhejiang University, Hangzhou, China.
4
College of Biosystem Engineering and Food Science, Zhejiang University, Hangzhou, China.

Abstract

The antioxidant effects of the triterpenoid-rich extracts from Euryale ferox shell (ES) have been confirmed in vitro. This study examined whether the triterpenoid-rich extract from ES eases human hyperglycemia and diabetes caused by metabolic disorders. Normal and streptozocin (STZ)-induced diabetic mice were used as controls for the four groups that received the triterpenoid-rich extracts of ES suspended in distilled water orally at doses of 200, 300, 400, 500±2 mg/L. Body weight, blood glucose and pancreatic tissue morphology were observed after 4 weeks. The expression of protein tyrosine phosphatase-1B (PTP1B) and insulin receptor substrate (IRS-1) proteins, which are related to the regulation of glucose metabolism in vivo, were also investigated. Compared with the model group (LD50 900±2 mg/L), it was found that the triterpenoid-rich extracts of ES could regulate glucose metabolism (P<0.01) and cause body weight to return to normal levels (P<0.05). Islet morphology recovered well, the expression of the negative regulation protein PTP1B gene was reduced and insulin receptor IRS-1 protein expression was increased. These data prove that the triterpenoid-rich extracts from ES have a therapeutic effect on diabetes by insulin resistance.

PMID:
25015452
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center